Recenti progressi in medicina 2013-04-01

[Prevention of post-operative recurrence in Crohn's disease: a critical review of randomized controlled trials and meta-analyses of different therapeutic strategies].

Giovanna Margagnoni, Valeria Clemente, Annalisa Aratari, Federica Fascì Spurio, Angela Maria De Gregorio, Annalisa Spagnolo, Maurizio Koch, Claudio Papi

Index: Recenti Prog. Med. 104(4) , 168-76, (2013)

Full Text: HTML

Abstract

Surgery is an almost inevitable event in Crohn's disease but is not curative; post-operative recurrence follows a sequential and predictable course. Prevention of post-operative recurrence in Crohn's disease is therefore a relevant problem in the management of the disease. Several drugs have been evaluated to decrease the risk of recurrence: these include mesalazine, antibiotics, probiotics, budesonide, thiopurines and biologic agents. This review focuses on the randomised controlled trials and meta-analyses addressing different drugs and strategies for preventing post-operative recurrence in Crohn's disease.

Related Compounds

  • 5-Aminosalicylic...
  • Budesonide

Related Articles:

Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.

2010-01-01

[Chem. Res. Toxicol. 23 , 171-83, (2010)]

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

2011-12-01

[J. Sci. Ind. Res. 65(10) , 808, (2006)]

Development and validation of an LC-MS/MS method for the determination of mesalazine in beagle dog plasma and its application to a pharmacokinetic study.

2015-02-01

[Biomed. Chromatogr. 29(2) , 261-7, (2015)]

A new approach for automated liquid-liquid extraction in a sequential injection manifold.

2015-01-01

[Anal. Bioanal. Chem 407(2) , 521-8, (2015)]

Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).

2008-06-12

[J. Med. Chem. 51 , 3275-87, (2008)]

More Articles...